U.S. mass tort: Suboxone tooth decay lit… | DrugsMonitor.com

Suboxone tooth decay litigation: educational case snapshot only; individualized legal advice requires consulting a qualified attorney—not legal advice.

buprenorphine naloxone film, dental erosion, cavities, oral injuries

Litigation involving Suboxone sublingual film alleges that long-term placement of buprenorphine/naloxone film under the tongue exposes teeth and gums to acidic conditions, contributing to severe decay, extractions, and oral surgery in some patients.

Clinical and product-use context

Suboxone film is designed to dissolve sublingually, delivering buprenorphine and naloxone as part of medication-assisted treatment. Plaintiffs’ complaints describe prolonged contact between dissolved medication and dental enamel, coupled with dry mouth or reduced saliva, as factors in rapid caries and tooth loss.

Defendants have disputed causation and labeling adequacy in court filings. As with any drug litigation, outcomes depend on individual medical histories, concurrent risk factors (tobacco use, prior dental disease, other medications), and evidentiary rulings.